Video: Expert provides perspective on FDA approval of another experimental Alzheimer’s drug

smart city and communication network. Smart city dot point connect .internet of things connection metaverse technology.

The Food and Drug Administration (FDA) granted accelerated approval of a disease-modifying treatment that could potentially give some patients with Alzheimer’s disease something they haven’t had before: a medication that may slow the decline of memory and thinking.

‘You’ Season 4 trailer: Joe chases a murderer instead of love

Previous article

Targeted care reverses racial/ethnic health disparities in colon cancer screening, researchers find

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in Innovations